Journal article

Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosis

MR McLean, KM Wragg, E Lopez, SA Kiazyk, TB Ball, J Bueti, SJ Kent, JA Juno, AW Chung

Clinical and Translational Immunology | Published : 2021

Abstract

Objectives: Tuberculosis comorbidity with chronic diseases including diabetes, HIV and chronic kidney disease is of rising concern. In particular, latent tuberculosis infection (LTBI) comorbidity with end-stage kidney disease (ESKD) is associated with up to 52.5-fold increased risk of TB reactivation to active tuberculosis infection (ATBI). The immunological mechanisms driving this significant rise in TB reactivation are poorly understood. To contribute to this understanding, we performed a comprehensive assessment of soluble and cellular immune features amongst a unique cohort of patients comorbid with ESKD and LTBI. Methods: We assessed the plasma and cellular immune profiles from patients..

View full abstract